Multiple Sclerosis
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
Novartis’ Kesimpta Notches FDA Approval as Targeted B-cell Therapy for Patients with Relapsing MS
2020-08-23
Novartis Reveals Positive Ofatumumab Data for Treating Relapsing Forms of Multiple sclerosis
2020-06-07